Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anteris Technologies Global Corp (AVR)

Anteris Technologies Global Corp (AVR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 205,166
  • Shares Outstanding, K 41,198
  • Annual Sales, $ 2,700 K
  • Annual Income, $ -76,290 K
  • EBIT $ -86 M
  • EBITDA $ -85 M
  • 60-Month Beta N/A
  • Price/Sales 80.02
  • Price/Cash Flow N/A
  • Price/Book 60.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.30 +50.91%
on 11/21/25
5.50 -9.45%
on 12/11/25
+1.09 (+28.02%)
since 11/12/25
3-Month
3.30 +50.91%
on 11/21/25
6.45 -22.79%
on 10/21/25
-0.59 (-10.59%)
since 09/12/25

Most Recent Stories

More News
Anteris Technologies Prepares for Annual Stockholder Meeting

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Anteris Technologies...

AVR : 4.98 (-5.14%)
Anteris Technologies Gains European Clearance for Heart Valve Trial

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

AVR : 4.98 (-5.14%)
Anteris Announces Completion of A$35 Million Capital Raise and Provides 2023 Goalposts

Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVR™, the world’s only balloon-expandable, 3D single-piece biomimetic aortic valve, announced today the completion of a...

AVR.AX : 7.270 (-3.45%)
AVR : 4.98 (-5.14%)
Anteris Technologies Receives FDA Clearance to Initiate Early Feasibility Study for its Novel TAVR Product, DurAVRâ„¢

Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVR™, the world’s only balloon-expandable, 3D single-piece aortic valve shaped to mimic the native human valve, today announced...

AVR.AX : 7.270 (-3.45%)
AVR : 4.98 (-5.14%)
Anteris Technologies Announces Presentation of First-In-Human Data for its Novel TAVR Product, DurAVRâ„¢ at the 2022 Annual TCT Congress in Boston

Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™, the world’s only balloon-expandable, 3D single-piece native shaped aortic valve, announced...

AVR.AX : 7.270 (-3.45%)
AVR : 4.98 (-5.14%)
Anteris Technologies Announces $20M Private Placement with Perceptive Advisors

BRISBANE, Australia and EAGAN, Minn., March 02, 2022 (GLOBE NEWSWIRE) -- Anteris Technologies Ltd (Anteris or the Company) Limited (ASX: AVR) announces...

AVR.AX : 7.270 (-3.45%)
AVR : 4.98 (-5.14%)

Business Summary

Anteris Technologies Global Corp. is involved in designing, developing and commercializing cutting-edge medical devices to restore healthy heart function. The company's lead product includes DurAVR(R). Anteris Technologies Global Corp. is based in BRISBANE, Australia.

See More

Key Turning Points

3rd Resistance Point 5.60
2nd Resistance Point 5.45
1st Resistance Point 5.21
Last Price 4.98
1st Support Level 4.82
2nd Support Level 4.67
3rd Support Level 4.43

See More

52-Week High 8.79
Fibonacci 61.8% 6.33
Fibonacci 50% 5.57
Last Price 4.98
Fibonacci 38.2% 4.80
52-Week Low 2.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar